p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability

Cancer Research

Volumn 57, Issue 18, 1997, Pages 4070-4074

  Liloglou, Triantafillos ^a,b   Scholes, Andrea G M ^a   Spandidos, Demetrios A ^c   Vaughan, E David ^d   Jones, Andrew S ^a   Field, John K ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Lung Cancer Research   (United Kingdom)

^c INSTITUTE OF BIOLOGY   (Greece)

^d WALTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; GENE MUTATION; GENETIC STABILITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA;

ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; ENGLAND; GENES, P53; HEAD AND NECK NEOPLASMS; HETEROZYGOTE; HUMANS; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE DELETION; SMOKING;

EID: 0030882091     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Decker, J., and Goldstein, J. C. Risk factors in head and neck cancer. N. Engl. J. Med., 306: 1151-1155, 1982.
2. Boyle, P., Macfarlane, G. J., Blot, W. J., Chiesa, F., Lefebvre, J. L., Azul, A. M., de Vries, N., and Scully, C. European school of oncology advisory report to the European commission for the Europe against cancer programme: oral carcinogenesis in Europe. Eur. J. Cancer, 31B: 75-85, 1995.
3. Somers, K. D., Merrick, M. A., Lopez, M. E., Incognito, L. S., Schlechter, G. L., and Casey, G. Frequent p53 mutations in head and neck cancer. Cancer Res., 52: 5997-6000, 1992.
4. Boyle, J. O., Hakim, J., Koch, W., van der Reit, P., Hruban, R. H., Rao, R. A., Correo, R., Rby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
5. Field, J. K., Spandidos, D. A., Malliri, A., Yiagnisis, M., Gosney, J. R., and Stell, P. M. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br. J. Cancer, 64: 573-577, 1991.
6. Field, J. K., Spandidos, D. A., and Stell, P. M. Overexpression of the p53 gene in head and neck cancer, linked with heavy smoking and drinking. Lancet, 339: 502-503, 1992.
7. Field, J. K., Zoumpourlis, V., Spandidos, D. A., and Jones, A. S. p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients use of tobacco and alcohol Cancer Detect. Prev., 18: 197-208, 1994.
8. Brennan, J. A., Boyle, J. O., Koch, W. M., Goodman, S. N., Hruban, R. H., Eby, Y. J., Couch, M. J., Forastiere, A. A., and Sidransky, D. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N. Engl. J. Med., 332: 712-717, 1995.
9. Lazarus, P., Garewal, H. S., Sciubba, J., Zwiebel, N., Calcagnotto, A., Fair, A., Schaefer, S., and Richie, J. P. A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users. Int. J. Cancer, 60: 458-463, 1995.
10. Waridel, F., Estreicher, A., Bron, L., Flaman, J. M., Fontolliet, C., Monnier, P., Frebourg, T., and Iggo, R. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene, 14: 163-169, 1997.
11. Vogelstein, B., and Kinzler, K. W. Carcinogens leave fingerprints. Nature (Lond.), 355: 209-210, 1992.
12. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
13. Zhang, X. L., and Mathews, C. K. Effect of DNA cytocine methylation upon deamination-induced mutagenesis in a natural target sequence in duplex DNA. J. Biol. Chem., 269: 7066-7069, 1994.
14. Shen, J. C., Rideout, W. M., and Jones, P. A. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res., 22: 972-976, 1994.
15. Malia, S. A., and Basu, A. K. Reductive metabolism of 1-nitropyrene accompanies deamination of cytosine. Chem. Res. Toxicol., 7: 823-828, 1994.
16. Privat, E., and Sowers, L. C. Photochemical deamination and demethylation of of 5-methylcytosine. Chem. Res. Toxicol., 9: 745-750, 1996.
17. Greenblatt, M. S., Grollman, A. P., and Harris, C. C. Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model. Cancer Res., 56: 2130-2136, 1996.
18. Bressac, B., Kew, M., Wands, J., and Ozturk, M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
19. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
20. Shen, H. M., and Ong, C. N. Mutations of the p53 tumor-suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutat. Res., 366: 23-44, 1996.
21. Eisenstadt, E., Warren, A. J., Porter, J., Atkins, D., and Miller, J. H. Carcinogenic epoxides of benzo(a)pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions. Proc. Natl. Acad. Sci. USA, 79: 1945-1949, 1982.
22. Denissenco, M. F., Pao, A., Tang, M-S., and Pfeifer, G. P. Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in p53. Science (Washington DC), 274: 430, 1996.
23. Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., and Ponten, J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 88: 10124-10128, 1991.
24. Moles, J-P., Moyret, C., Guillot, B., Jeanteur, P., Guilhou, J-J., Theillet, C., and Basset-Seguin, N. p53 gene mutations in human epithelial skin cancers. Oncogene, 8: 583-588, 1993.
25. Chiba, I., Takahashi, T., Nau, M. M., D'Amico, D., Curiel, D. T., Mitsudomi, T., Buchhagen, D. L., Carbone, D., Piantadosi, S., Koga, H., Reissman, P. T., Slamon, D. J., Holmes, E. C., and Minna, J. D. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
26. Iggo, R., Gatter, K., Bartek, J., Lane, D., and Harris, A. L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335: 675-679, 1990.
27. Suzuki, H., Takahashi, T., Kuroishi, T., Suyama, M., Ariyoshi, Y., Takahashi, T., and Ueda, R. p53 Mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res., 52: 734-736, 1992.
28. Lehman, T. A., Bennett, W. P., Metcalf, R. A., Welsh, J. A., Ecker, J., Modali, R. V., Ullrich, S., Romano, J. W., Appella, E., Testa, J. R., Gerwin, B. I., and Harris, C. C. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res., 51: 4090-4096, 1991.
29. Field, J. K., Kiaris, H., Risk, J. M., Tsiriyotis, C. Adamson, R., Zoumpourlis, V., Rowley, H., Taylor, K., Whittaker, S., Howard, P., Beirnie, J. C., Gosney, J. R., Woolgar, J., Vaughan, E. D., Spandidos, D. A., and Jones, A. S. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br. J. Cancer, 72: 1180-1188, 1995.
30. Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R., and Harris, C. C. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res., 24: 141-146, 1996.
31. Guitterplan, J. B. Mutagenic activity in smokeless tobacco products sold in the USA. Carcinogenesis (Lond.), 8: 741-743, 1987.
32. Wynder, E. L., and Hoffman, D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res., 54: 5284-5295, 1994.
33. Liloglou, T., Ross, H., Prime, W., Neville, E. M., Stewart, M. P., Donnelly, R. J., Spandidos, D. A., Gosney, J. R., and Field, J. K. p53 gene aberrations in non-small cell lung carcinomas from a smoking population. Br. J. Cancer, 75: 1119-1124, 1997
34. Huang, Y., Meltzer, S. J., Yin, J., Tong, Y., Chang, E. H., Srivastara, S., and McDaniel, T. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res., 53: 1889-1894, 1993.
35. Liang, Y-Y., Esteve, A., Martel-Planche, G., Takahashi, S., Lu, S-H., Montesano, R., and Holstein, M. p53 mutations in esophageal tumors from high-incidence areas of China. Int. J. Cancer, 61: 611-614, 1995.
36. Law, J. C., Whiteside, T. L., Gollin, S. M., Weisfeld, J., El-Ashmawy, L., Srivastara, S., Landreneau, R. J., Johnson, J. T., and Ferrell, R. E. Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract. Clin. Cancer Res., 1: 763-768, 1995.
37. Renault, B., Calistri, D., Buosanti, G., Nanni, O., Amadori, D., and Ranzani, G. N. Microsatellite instability and mutations of p53 and TGF-β RII genes in gastric cancer. Hum. Genet., 98: 601-607, 1996.
38. Kahlenberg, M. S., Stoler, D. L., Basik, M., Petrelli, N. J., Rodriguezbigas, M., and Anderson, G. R. p53 tumor-suppressor gene status and the degree of genomic instability in sporadic colorectal cancers. J. Natl. Cancer Inst. (Bethesda), 88: 1665-1670, 1996.
39. Vet, J. A. M., Bringuier, P. P., Poddighe, P. J., Karthaus, H. F. M., Debruyne, F. M. J., and Schalken, J. A. p53 mutations have no additional prognostic value over stage in bladder cancer. Br. J. Cancer, 70: 496-500, 1994.
40. Sood, A. K., Skilling J. S., and Buller R. E. Ovarian cancer genomic instability correlates with p53 frameshift mutations. Cancer Res., 57: 1047-1049, 1997.
41. Valgardsdottir, R., Trysgvadottir, L., Steinarsdottir, M., Olafsdottir, K., Jonasdottir, S., Jonasson, J. G., Ogmundsdottir, H. M., and Eyfjord, J. E. Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and Immunohistochemical analysis. APMIS, 105: 121-130, 1997.